M
Marion Simonetta-Moreau
Researcher at French Institute of Health and Medical Research
Publications - 54
Citations - 2046
Marion Simonetta-Moreau is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transcranial magnetic stimulation & H-reflex. The author has an hindex of 24, co-authored 52 publications receiving 1811 citations. Previous affiliations of Marion Simonetta-Moreau include University of Toulouse & Paul Sabatier University.
Papers
More filters
Journal ArticleDOI
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
Angélique Gerdelat-Mas,Marion Simonetta-Moreau,Claire Thalamas,Fabienne Ory-Magne,T. Slaoui,O. Rascol,Christine Brefel-Courbon +6 more
TL;DR: Evidence of a dopaminergic modulation of objective pain threshold in Parkinson’s disease patients is provided and the decrease in RIII threshold in PD patients, in the OFF condition, compared with controls, confirms the existence of an objective pain perception disturbance in PD.
Journal ArticleDOI
Square wave jerks in parkinsonian syndromes.
Olivier Rascol,Umberto Sabatini,Marion Simonetta-Moreau,Jean-Louis Montastruc,André Rascol,Michel Clanet +5 more
TL;DR: Square wave jerks are probably not related to the central degeneration of the dopaminergic nigrostriatal pathway observed in PD and may help to differentiate PD clinically from other Parkinsonian syndromes.
Journal ArticleDOI
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects
Angélique Gerdelat-Mas,Isabelle Loubinoux,David Tombari,Olivier Rascol,François Chollet,Marion Simonetta-Moreau +5 more
TL;DR: The different modulation of RC and ICF after chronic administration of paroxetine compared to single dose (opposite effects) emphasizes the different pharmacological action of the drug at cortical level depending on its acute or long-term administration.
Journal ArticleDOI
Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients
TL;DR: These results reflect a facilitation of the transmission in the interneuronal pathway coactivated by group I and group II afferents, probably resulting from a change in their descending control in spastic hemiplegic patients.
Journal ArticleDOI
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
Fabienne Ory-Magne,Christine Brefel-Courbon,Marion Simonetta-Moreau,Nelly Fabre,Jean Albert Lotterie,Patrick Chaynes,Isabelle Berry,Yves Lazorthes,Olivier Rascol +8 more
TL;DR: A longer follow‐up duration and a larger population seem necessary to better assess the quality of life perception in elderly patients and to determinate the real risk of hemorrage.